Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Apr;5(2):144–169. doi: 10.1155/S0962935196000221

L'inflammation dans la Mucoviscidose

PMCID: PMC2365778  PMID: 18475711

Full Text

The Full Text of this article is available as a PDF (3.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1. [DOI] [PubMed] [Google Scholar]
  2. Antoniades H. N., Bravo M. A., Avila R. E., Galanopoulos T., Neville-Golden J., Maxwell M., Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest. 1990 Oct;86(4):1055–1064. doi: 10.1172/JCI114808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arend W. P., Dayer J. M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995 Feb;38(2):151–160. doi: 10.1002/art.1780380202. [DOI] [PubMed] [Google Scholar]
  4. Armstrong D. S., Grimwood K., Carzino R., Carlin J. B., Olinsky A., Phelan P. D. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ. 1995 Jun 17;310(6994):1571–1572. doi: 10.1136/bmj.310.6994.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Babior B. M. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978 Mar 23;298(12):659–668. doi: 10.1056/NEJM197803232981205. [DOI] [PubMed] [Google Scholar]
  6. Bajolet-Laudinat O., Girod-de Bentzmann S., Tournier J. M., Madoulet C., Plotkowski M. C., Chippaux C., Puchelle E. Cytotoxicity of Pseudomonas aeruginosa internal lectin PA-I to respiratory epithelial cells in primary culture. Infect Immun. 1994 Oct;62(10):4481–4487. doi: 10.1128/iai.62.10.4481-4487.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baltimore R. S., Christie C. D., Smith G. J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis. 1989 Dec;140(6):1650–1661. doi: 10.1164/ajrccm/140.6.1650. [DOI] [PubMed] [Google Scholar]
  8. Becq F., Merten M. D., Voelckel M. A., Gola M., Figarella C. Characterization of cAMP dependent CFTR-chloride channels in human tracheal gland cells. FEBS Lett. 1993 Apr 19;321(1):73–78. doi: 10.1016/0014-5793(93)80624-4. [DOI] [PubMed] [Google Scholar]
  9. Birrer P., McElvaney N. G., Rüdeberg A., Sommer C. W., Liechti-Gallati S., Kraemer R., Hubbard R., Crystal R. G. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med. 1994 Jul;150(1):207–213. doi: 10.1164/ajrccm.150.1.7912987. [DOI] [PubMed] [Google Scholar]
  10. Bonfield T. L., Konstan M. W., Burfeind P., Panuska J. R., Hilliard J. B., Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol. 1995 Sep;13(3):257–261. doi: 10.1165/ajrcmb.13.3.7544594. [DOI] [PubMed] [Google Scholar]
  11. Bonfield T. L., Panuska J. R., Konstan M. W., Hilliard K. A., Hilliard J. B., Ghnaim H., Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111–2118. doi: 10.1164/ajrccm.152.6.8520783. [DOI] [PubMed] [Google Scholar]
  12. Bories D., Raynal M. C., Solomon D. H., Darzynkiewicz Z., Cayre Y. E. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell. 1989 Dec 22;59(6):959–968. doi: 10.1016/0092-8674(89)90752-6. [DOI] [PubMed] [Google Scholar]
  13. Boutten A., Dehoux M. S., Seta N., Ostinelli J., Venembre P., Crestani B., Dombret M. C., Durand G., Aubier M. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1996 Jan;153(1):336–342. doi: 10.1164/ajrccm.153.1.8542140. [DOI] [PubMed] [Google Scholar]
  14. Brody S. L., Metzger M., Danel C., Rosenfeld M. A., Crystal R. G. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther. 1994 Jul;5(7):821–836. doi: 10.1089/hum.1994.5.7-821. [DOI] [PubMed] [Google Scholar]
  15. Brown R. K., Kelly F. J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res. 1994 Oct;36(4):487–493. doi: 10.1203/00006450-199410000-00013. [DOI] [PubMed] [Google Scholar]
  16. Brown R. K., Kelly F. J. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax. 1994 Aug;49(8):738–742. doi: 10.1136/thx.49.8.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Brown R. K., McBurney A., Lunec J., Kelly F. J. Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med. 1995 Apr;18(4):801–806. doi: 10.1016/0891-5849(94)00172-g. [DOI] [PubMed] [Google Scholar]
  18. Brown R. K., Wyatt H., Price J. F., Kelly F. J. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J. 1996 Feb;9(2):334–339. doi: 10.1183/09031936.96.09020334. [DOI] [PubMed] [Google Scholar]
  19. Burger D., Chicheportiche R., Giri J. G., Dayer J. M. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest. 1995 Jul;96(1):38–41. doi: 10.1172/JCI118045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Burnett D., Chamba A., Hill S. L., Stockley R. A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet. 1987 Nov 7;2(8567):1043–1046. doi: 10.1016/s0140-6736(87)91476-0. [DOI] [PubMed] [Google Scholar]
  21. Burnett D., Ward C. J., Stockley R. A., Dalton R. G., Cant A. J., Hoare S., Crocker J. Neutrophil elastase and cathepsin G protein and messenger RNA expression in bone marrow from a patient with Chediak-Higashi syndrome. Clin Mol Pathol. 1995 Feb;48(1):M28–M34. doi: 10.1136/mp.48.1.m28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Cabellos C., MacIntyre D. E., Forrest M., Burroughs M., Prasad S., Tuomanen E. Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest. 1992 Aug;90(2):612–618. doi: 10.1172/JCI115900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Crestani B., Cornillet P., Dehoux M., Rolland C., Guenounou M., Aubier M. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest. 1994 Aug;94(2):731–740. doi: 10.1172/JCI117392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Crystal R. G., Jaffe A., Brody S., Mastrangeli A., McElvaney N. G., Rosenfeld M., Chu C. S., Danel C., Hay J., Eissa T. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum Gene Ther. 1995 May;6(5):643–666. doi: 10.1089/hum.1995.6.5-643. [DOI] [PubMed] [Google Scholar]
  25. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
  26. Crystal R. G. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med. 1991 Sep 30;91(3C):39S–44S. doi: 10.1016/0002-9343(91)90282-3. [DOI] [PubMed] [Google Scholar]
  27. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  28. Danel C., Erzurum S. C., McElvaney N. G., Crystal R. G. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am J Respir Crit Care Med. 1996 Jan;153(1):362–368. doi: 10.1164/ajrccm.153.1.8542144. [DOI] [PubMed] [Google Scholar]
  29. Dehoux M. S., Boutten A., Ostinelli J., Seta N., Dombret M. C., Crestani B., Deschenes M., Trouillet J. L., Aubier M. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1994 Sep;150(3):710–716. doi: 10.1164/ajrccm.150.3.8087341. [DOI] [PubMed] [Google Scholar]
  30. Eigen H., Rosenstein B. J., FitzSimmons S., Schidlow D. V. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr. 1995 Apr;126(4):515–523. doi: 10.1016/s0022-3476(95)70343-8. [DOI] [PubMed] [Google Scholar]
  31. Engelhardt J. F., Yankaskas J. R., Ernst S. A., Yang Y., Marino C. R., Boucher R. C., Cohn J. A., Wilson J. M. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet. 1992 Nov;2(3):240–248. doi: 10.1038/ng1192-240. [DOI] [PubMed] [Google Scholar]
  32. Engelhardt J. F., Zepeda M., Cohn J. A., Yankaskas J. R., Wilson J. M. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest. 1994 Feb;93(2):737–749. doi: 10.1172/JCI117028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gallin J. I., Leto T. L., Rotrosen D., Kwong C. H., Malech H. L. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. Curr Opin Immunol. 1992 Feb;4(1):53–56. doi: 10.1016/0952-7915(92)90124-w. [DOI] [PubMed] [Google Scholar]
  34. Goldstein W., Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Jul;134(1):49–56. doi: 10.1164/arrd.1986.134.1.49. [DOI] [PubMed] [Google Scholar]
  35. Goldstein W., Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Jul;134(1):49–56. doi: 10.1164/arrd.1986.134.1.49. [DOI] [PubMed] [Google Scholar]
  36. Hahon N., Castranova V. Interferon production in rat type II pneumocytes and alveolar macrophages. Exp Lung Res. 1989 May;15(3):429–445. doi: 10.3109/01902148909087869. [DOI] [PubMed] [Google Scholar]
  37. Han J., Unlap T., Rado T. A. Expression of the human neutrophil elastase gene: positive and negative transcriptional elements in the 5' flanking region. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1462–1468. doi: 10.1016/0006-291x(91)92104-r. [DOI] [PubMed] [Google Scholar]
  38. Heiss L. N., Lancaster J. R., Jr, Corbett J. A., Goldman W. E. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):267–270. doi: 10.1073/pnas.91.1.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Heusel J. W., Hanson R. D., Silverman G. A., Ley T. J. Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem. 1991 Apr 5;266(10):6152–6158. [PubMed] [Google Scholar]
  40. Isler P., Vey E., Zhang J. H., Dayer J. M. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw. 1993 Jan-Feb;4(1):15–23. [PubMed] [Google Scholar]
  41. Jacquot J., Puchelle E., Hinnrasky J., Fuchey C., Bettinger C., Spilmont C., Bonnet N., Dieterle A., Dreyer D., Pavirani A. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J. 1993 Feb;6(2):169–176. [PubMed] [Google Scholar]
  42. Kanthakumar K., Taylor G., Tsang K. W., Cundell D. R., Rutman A., Smith S., Jeffery P. K., Cole P. J., Wilson R. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun. 1993 Jul;61(7):2848–2853. doi: 10.1128/iai.61.7.2848-2853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kemp T., Schram-Doumont A., van Geffel R., Kram R., Szpirer C. Alteration of the N-formyl-methionyl-leucyl-phenylalanine-induced response in cystic fibrosis neutrophils. Pediatr Res. 1986 Jun;20(6):520–526. doi: 10.1203/00006450-198606000-00008. [DOI] [PubMed] [Google Scholar]
  44. Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K. C., Kemp A., Bereznay O. H., Greenberg A. H. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991 Aug;5(2):155–162. doi: 10.1165/ajrcmb/5.2.155. [DOI] [PubMed] [Google Scholar]
  45. Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995 Apr;151(4):1075–1082. doi: 10.1164/ajrccm/151.4.1075. [DOI] [PubMed] [Google Scholar]
  46. Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995 Apr;151(4):1075–1082. doi: 10.1164/ajrccm/151.4.1075. [DOI] [PubMed] [Google Scholar]
  47. Klebanoff S. J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol. 1968 Jun;95(6):2131–2138. doi: 10.1128/jb.95.6.2131-2138.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Koller D. Y., Götz M., Eichler I., Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax. 1994 May;49(5):496–499. doi: 10.1136/thx.49.5.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Konstan M. W., Byard P. J., Hoppel C. L., Davis P. B. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995 Mar 30;332(13):848–854. doi: 10.1056/NEJM199503303321303. [DOI] [PubMed] [Google Scholar]
  50. Konstan M. W., Hilliard K. A., Norvell T. M., Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994 Aug;150(2):448–454. doi: 10.1164/ajrccm.150.2.8049828. [DOI] [PubMed] [Google Scholar]
  51. Konstan M. W., Hilliard K. A., Norvell T. M., Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994 Aug;150(2):448–454. doi: 10.1164/ajrccm.150.2.8049828. [DOI] [PubMed] [Google Scholar]
  52. Konstan M. W., Vargo K. M., Davis P. B. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. Am Rev Respir Dis. 1990 Jan;141(1):186–192. doi: 10.1164/ajrccm/141.1.186. [DOI] [PubMed] [Google Scholar]
  53. Koyama S., Kobayashi T., Kubo K., Sekiguchi M., Ueda G. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep. Am Rev Respir Dis. 1992 Jun;145(6):1404–1409. doi: 10.1164/ajrccm/145.6.1404. [DOI] [PubMed] [Google Scholar]
  54. Lacraz S., Isler P., Vey E., Welgus H. G., Dayer J. M. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem. 1994 Sep 2;269(35):22027–22033. [PubMed] [Google Scholar]
  55. Lacraz S., Nicod L. P., Chicheportiche R., Welgus H. G., Dayer J. M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995 Nov;96(5):2304–2310. doi: 10.1172/JCI118286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Langley S. C., Brown R. K., Kelly F. J. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res. 1993 Mar;33(3):247–250. doi: 10.1203/00006450-199303000-00008. [DOI] [PubMed] [Google Scholar]
  57. Leff J. A., Wilke C. P., Hybertson B. M., Shanley P. F., Beehler C. J., Repine J. E. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am J Physiol. 1993 Nov;265(5 Pt 1):L501–L506. doi: 10.1152/ajplung.1993.265.5.L501. [DOI] [PubMed] [Google Scholar]
  58. Mastrangeli A., Danel C., Rosenfeld M. A., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J. P., Crystal R. G. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest. 1993 Jan;91(1):225–234. doi: 10.1172/JCI116175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Matheson N. R., Wong P. S., Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun. 1979 May 28;88(2):402–409. doi: 10.1016/0006-291x(79)92062-x. [DOI] [PubMed] [Google Scholar]
  60. McElvaney N. G., Hubbard R. C., Birrer P., Chernick M. S., Caplan D. B., Frank M. M., Crystal R. G. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet. 1991 Feb 16;337(8738):392–394. doi: 10.1016/0140-6736(91)91167-s. [DOI] [PubMed] [Google Scholar]
  61. Meyer K. C., Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med. 1993 May;121(5):654–661. [PubMed] [Google Scholar]
  62. Munoz C., Carlet J., Fitting C., Misset B., Blériot J. P., Cavaillon J. M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991 Nov;88(5):1747–1754. doi: 10.1172/JCI115493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Nicod L. P., Galve-De-Rochemonteix B., Dayer J. M. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann N Y Acad Sci. 1994 May 28;725:323–330. doi: 10.1111/j.1749-6632.1994.tb39815.x. [DOI] [PubMed] [Google Scholar]
  64. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988 Apr;81(4):1162–1172. doi: 10.1172/JCI113431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Passo S. A., Weiss S. J. Oxidative mechanisms utilized by human neutrophils to destroy Escherichia coli. Blood. 1984 Jun;63(6):1361–1368. [PubMed] [Google Scholar]
  66. Perlmutter D. H., May L. T., Sehgal P. B. Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest. 1989 Jul;84(1):138–144. doi: 10.1172/JCI114133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Plotkowski M. C., Puchelle E., Beck G., Jacquot J., Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis. 1986 Nov;134(5):1040–1044. doi: 10.1164/arrd.1986.134.5.1040. [DOI] [PubMed] [Google Scholar]
  68. Plotkowski M. C., Tournier J. M., Puchelle E. Pseudomonas aeruginosa strains possess specific adhesins for laminin. Infect Immun. 1996 Feb;64(2):600–605. doi: 10.1128/iai.64.2.600-605.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Portal B. C., Richard M. J., Faure H. S., Hadjian A. J., Favier A. E. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1995 Apr;61(4):843–847. doi: 10.1093/ajcn/61.4.843. [DOI] [PubMed] [Google Scholar]
  70. Prince G. A., Porter D. D., Jenson A. B., Horswood R. L., Chanock R. M., Ginsberg H. S. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol. 1993 Jan;67(1):101–111. doi: 10.1128/jvi.67.1.101-111.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Regelmann W. E., Lunde N. M., Porter P. T., Quie P. G. Increased monocyte chemiluminescence in cystic fibrosis patients and in their parents. Pediatr Res. 1986 Jul;20(7):619–622. doi: 10.1203/00006450-198607000-00008. [DOI] [PubMed] [Google Scholar]
  72. Roberts R. L., Stiehm E. R. Increased phagocytic cell chemiluminescence in patients with cystic fibrosis. Am J Dis Child. 1989 Aug;143(8):944–950. doi: 10.1001/archpedi.1989.02150200104027. [DOI] [PubMed] [Google Scholar]
  73. Rosenfeld M. A., Chu C. S., Seth P., Danel C., Banks T., Yoneyama K., Yoshimura K., Crystal R. G. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther. 1994 Mar;5(3):331–342. doi: 10.1089/hum.1994.5.3-331. [DOI] [PubMed] [Google Scholar]
  74. Rosenfeld M. A., Collins F. S. Gene therapy for cystic fibrosis. Chest. 1996 Jan;109(1):241–252. doi: 10.1378/chest.109.1.241. [DOI] [PubMed] [Google Scholar]
  75. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  76. Rugo H. S., O'Hanley P., Bishop A. G., Pearce M. K., Abrams J. S., Howard M., O'Garra A. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest. 1992 Mar;89(3):1032–1039. doi: 10.1172/JCI115644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  78. Sibille Y., Reynolds H. Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990 Feb;141(2):471–501. doi: 10.1164/ajrccm/141.2.471. [DOI] [PubMed] [Google Scholar]
  79. Sies H. Antioxidant activity in cells and organs. Am Rev Respir Dis. 1987 Aug;136(2):478–480. doi: 10.1164/ajrccm/136.2.478. [DOI] [PubMed] [Google Scholar]
  80. Simon R. H., Engelhardt J. F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J. M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther. 1993 Dec;4(6):771–780. doi: 10.1089/hum.1993.4.6-771. [DOI] [PubMed] [Google Scholar]
  81. Snider G. L., Lucey E. C., Christensen T. G., Stone P. J., Calore J. D., Catanese A., Franzblau C. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis. 1984 Jan;129(1):155–160. doi: 10.1164/arrd.1984.129.1.155. [DOI] [PubMed] [Google Scholar]
  82. Snouwaert J. N., Brigman K. K., Latour A. M., Malouf N. N., Boucher R. C., Smithies O., Koller B. H. An animal model for cystic fibrosis made by gene targeting. Science. 1992 Aug 21;257(5073):1083–1088. doi: 10.1126/science.257.5073.1083. [DOI] [PubMed] [Google Scholar]
  83. Srikanth S., Rado T. A. A 30-base pair element is responsible for the myeloid-specific activity of the human neutrophil elastase promoter. J Biol Chem. 1994 Dec 23;269(51):32626–32633. [PubMed] [Google Scholar]
  84. Standiford T. J., Kunkel S. L., Basha M. A., Chensue S. W., Lynch J. P., 3rd, Toews G. B., Westwick J., Strieter R. M. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest. 1990 Dec;86(6):1945–1953. doi: 10.1172/JCI114928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Standiford T. J., Kunkel S. L., Phan S. H., Rollins B. J., Strieter R. M. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991 May 25;266(15):9912–9918. [PubMed] [Google Scholar]
  86. Stockley R. A. Bronchiectasis--new therapeutic approaches based on pathogenesis. Clin Chest Med. 1987 Sep;8(3):481–494. [PubMed] [Google Scholar]
  87. Suter S., Chevallier I., Krause K. H., Lew D. P. Effect of cyclic adenosine monophosphate elevations on functional responses of polymorphonuclear leukocytes from patients with cystic fibrosis. Pediatr Pulmonol. 1989;6(4):237–241. doi: 10.1002/ppul.1950060405. [DOI] [PubMed] [Google Scholar]
  88. Tanaka E., Yuba Y., Sato A., Kuze F. Effects of the beige mutation on respiratory tract infection with Pseudomonas aeruginosa in mice. Exp Lung Res. 1994 Jul-Aug;20(4):351–366. doi: 10.3109/01902149409064392. [DOI] [PubMed] [Google Scholar]
  89. Tanner J., Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest. 1991 Jul;88(1):239–247. doi: 10.1172/JCI115283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Tazi A., Bouchonnet F., Grandsaigne M., Boumsell L., Hance A. J., Soler P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest. 1993 Feb;91(2):566–576. doi: 10.1172/JCI116236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Thibeault D. W., Rezaiekhaligh M., Mabry S., Beringer T. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally. Pediatr Pulmonol. 1991;11(4):318–327. doi: 10.1002/ppul.1950110408. [DOI] [PubMed] [Google Scholar]
  92. Tournier J. M., Merten M., Meckler Y., Hinnrasky J., Fuchey C., Puchelle E. Culture and characterization of human tracheal gland cells. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1280–1288. doi: 10.1164/ajrccm/141.5_Pt_1.1280. [DOI] [PubMed] [Google Scholar]
  93. Tuomanen E. I., Austrian R., Masure H. R. Pathogenesis of pneumococcal infection. N Engl J Med. 1995 May 11;332(19):1280–1284. doi: 10.1056/NEJM199505113321907. [DOI] [PubMed] [Google Scholar]
  94. Tuomanen E., Pollack H., Parkinson A., Davidson M., Facklam R., Rich R., Zak O. Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci. J Infect Dis. 1988 Jul;158(1):36–43. doi: 10.1093/infdis/158.1.36. [DOI] [PubMed] [Google Scholar]
  95. Tuomanen E., Rich R., Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis. 1987 Apr;135(4):869–874. doi: 10.1164/arrd.1987.135.4.869. [DOI] [PubMed] [Google Scholar]
  96. Ulich T. R., Yin S., Guo K., Yi E. S., Remick D., del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991 May;138(5):1097–1101. [PMC free article] [PubMed] [Google Scholar]
  97. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med. 1989 Dec 1;170(6):1859–1867. doi: 10.1084/jem.170.6.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Weiss S. J., Lampert M. B., Test S. T. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science. 1983 Nov 11;222(4624):625–628. doi: 10.1126/science.6635660. [DOI] [PubMed] [Google Scholar]
  100. Welsh M. J., Smith A. E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993 Jul 2;73(7):1251–1254. doi: 10.1016/0092-8674(93)90353-r. [DOI] [PubMed] [Google Scholar]
  101. Welsh M. J., Smith A. E., Zabner J., Rich D. P., Graham S. M., Gregory R. J., Pratt B. M., Moscicki R. A. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum Gene Ther. 1994 Feb;5(2):209–219. doi: 10.1089/hum.1994.5.2-209. [DOI] [PubMed] [Google Scholar]
  102. Wilmott R. W., Kassab J. T., Kilian P. L., Benjamin W. R., Douglas S. D., Wood R. E. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis. 1990 Aug;142(2):365–368. doi: 10.1164/ajrccm/142.2.365. [DOI] [PubMed] [Google Scholar]
  103. Wilson J. M., Engelhardt J. F., Grossman M., Simon R. H., Yang Y. Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial. Hum Gene Ther. 1994 Apr;5(4):501–519. doi: 10.1089/hum.1994.5.4-501. [DOI] [PubMed] [Google Scholar]
  104. Wilson J. M. Gene therapy for cystic fibrosis: challenges and future directions. J Clin Invest. 1995 Dec;96(6):2547–2554. doi: 10.1172/JCI118318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Wilson J. M. Gene therapy for cystic fibrosis: challenges and future directions. J Clin Invest. 1995 Dec;96(6):2547–2554. doi: 10.1172/JCI118318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Witko-Sarsat V., Delacourt C., Rabier D., Bardet J., Nguyen A. T., Descamps-Latscha B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1910–1916. doi: 10.1164/ajrccm.152.6.8520754. [DOI] [PubMed] [Google Scholar]
  107. Witko-Sarsat V., Descamps-Latscha B. Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation. Mediators Inflamm. 1994;3(4):257–273. doi: 10.1155/S0962935194000360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Yei S., Mittereder N., Wert S., Whitsett J. A., Wilmott R. W., Trapnell B. C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther. 1994 Jun;5(6):731–744. doi: 10.1089/hum.1994.5.6-731. [DOI] [PubMed] [Google Scholar]
  109. Yoo J. H., Erzurum S. C., Hay J. G., Lemarchand P., Crystal R. G. Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest. 1994 Jan;93(1):297–302. doi: 10.1172/JCI116959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Zahm J. M., Chevillard M., Puchelle E. Wound repair of human surface respiratory epithelium. Am J Respir Cell Mol Biol. 1991 Sep;5(3):242–248. doi: 10.1165/ajrcmb/5.3.242. [DOI] [PubMed] [Google Scholar]
  111. Zhou D., Munster A., Winchurch R. A. Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. FASEB J. 1991 Aug;5(11):2582–2585. doi: 10.1096/fasebj.5.11.1868982. [DOI] [PubMed] [Google Scholar]
  112. Zimmer M., Medcalf R. L., Fink T. M., Mattmann C., Lichter P., Jenne D. E. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8215–8219. doi: 10.1073/pnas.89.17.8215. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES